Berkshire doubles Teva stake adds to Apple, ends a newspaper bet
Berkshire doubles Teva stake, adds to Apple, ends a newspaper bet. Warren Buffett’s Berkshire Hathaway on Tuesday said it has more than doubled its investment in generic drugmaker Teva Pharmaceutical and confirmed it has become Apple’s second-largest shareholder
Berkshire also shed an investment dating to the mid-1970s that reflected Buffett’s longstanding love for newspapers, selling its stake in Graham Holdings, the former publisher of the Washington Post. The changes were disclosed in a regulatory filing detailing Berkshire’s U.S.-listed stock holdings as of March 31. Read more .here
Berkshire said it owned about 40.5 million Teva American depositary receipts (ADRs) worth about $693 million as of March 31, up from 18.9 million ADRs three months earlier.
The disclosure was made in a filing with the U.S. Securities and Exchange Commission detailing Berkshire's U.S.-listed stock holdings as of March 31.